Tuani, Renalyn C.

HRN: 11-89-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2025
CEFUROXIME 1.5GM (VIAL)
11/22/2025
11/24/2025
IV
1.5gm X 3 Doses
Q8hr
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines